Compound class:
Synthetic organic
Comment: Compound 13B is a potent stereoselective mitofusin activator [1]. It was developed as a potential lead compound for the mitochondrial disorder Charcot-Marie-tooth disease 2A, that is caused by mutation in the MFN2 gene. The activator enhances mitochondrial fusion and improves mitochondrial dynamics. It has a favourable ADME profile and in vivo target engagement is observed.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-(trans-4-Hydroxycyclohexyl)-6-phenylhexanamide |
Database Links | |
GtoPdb PubChem SID | 434122138 |
PubChem CID | 154665740 |
Search Google for chemical match using the InChIKey | SUKXKLNDBLNTSW-QAQDUYKDSA-N |
Search Google for chemicals with the same backbone | SUKXKLNDBLNTSW |
UniChem Compound Search for chemical match using the InChIKey | SUKXKLNDBLNTSW-QAQDUYKDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SUKXKLNDBLNTSW-QAQDUYKDSA-N |